Brought to you by:
Integration of 3D imaging and optimized 3D robotic control set to be ‘important’ part of vascular surgery future
NEW YORK—The marriage of 3D imaging and robotics in hybrid operating suites promises to be a pivotal aspect of the future in vascular surgery—part of advances in the field that down the road will see surgeons look back on the…
‘No evidence’ to suggest spinal cord injury is decreased by prophylactic drainage during EVAR procedures
MIAMI—Cerebrospinal fluid (CSF) drainage is a key component in the treatment of spinal cord injury but the evidence that prophylactic drainage decreases such injury during endovascular repair (EVAR) is “at best weak,” Gustavo S. Oderich, MD, told the Critical Issues…
New meta-analysis finds ‘no observed difference’ in mortality between paclitaxel and uncoated device use in CLTI patients
February 2020 brings another paclitaxel device meta-analysis of randomized controlled trials in chronic limb-threatening ischemia (CLTI) patients. Krystal Dinh, BMed, of Westmead Hospital, Sydney, Australia, et al report online ahead of print that the risk of all-cause mortality after treatment with…
FDA keeps close watch on heparin dosing reports
The Food and Drug Administration (FDA) is closely monitoring reports of higher than usual doses of heparin being required to achieve activated clotting times (ACT) during cardiac procedures. The FDA “is aware of spontaneous adverse event reports submitted to FDA’s…
Drug-coated technology question aired during SAVS opening session
PALM BEACH, Fla.—Discussion of the drug-coated technology issue was piqued during the opening session of the Southern Association for Vascular Surgery (SAVS) annual meeting (Jan. 8–11) in Palm Beach, Florida. William P. Robinson III, MD, professor and chief in the…
CMS publishes 2020 round of coding changes for vascular surgeons
The Centers for Medicare and Medicaid Services (CMS) has provided some light reading with the publication of the Physician Fee Schedule (PFS), Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems, as well as Quality Reporting Programs final rules…
SVS and STS release new reporting standards for type B aortic dissections
The Society for Vascular Surgery (SVS) and the Society of Thoracic Surgeons (STS) have released new reporting standards to ensure patients with type B aortic dissections (TBADs) receive appropriate treatment and care. The care of patients with type B dissections…
‘Cardiovascular disease at crossroads’: practitioners call for a definitive randomized trial comparing precision medicine and polypill
The prospect of death rates from cardiovascular disease once again ticking upward after more than a half century of decline has led to a call for a randomized trial comparing the two new—and distinct—approaches to prevention: precision medicine and the…
Initial results from first-in-man trial of prosthetic VenoValve demonstrate promise, says investigator
PALM BEACH, Fla.—The initial results of an ongoing first-in-man study in Colombia that saw the implantation of a prosthetic venous valve in 15 patients appear promising, with improvement in clinical outcomes and quality of life evaluation, delegates at the Southern…
SVS president presents point-by-point defense of Society position on paclitaxel controversy
NEW YORK—Kim Hodgson, MD, president of the Society for Vascular Surgery, delivered a robust defense of the SVS position on the drug-coated balloon (DCB) and drug-eluting stent (DES) issue that is currently enveloping the vascular community during the 2019 iteration…